Study identifier:4522IL/0054
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A 30-Week, Forced-titration and Randomised, Crossover, Multicentre, Multinational Trial to Evaluate the Efficacy and Safety of ZD4522 and Atorvastatin in Subjects with Homozygous Familial Hypercholesterolaemia (4522IL/0054): Report of the First 18 Weeks of Treatment (Open label ZD4522 20/40/80 mg, Forced-titration Period)
dyslipidaemia
Phase 3
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|